查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1468258

2024-2032 年癌症惡病質市場報告（依治療方法、作用方式、配銷通路和地區）

Cancer Cachexia Market Report by Therapeutics, Mode of Action, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年，全球癌症惡病質市場規模達21億美元。

癌症惡病質是指多因素的宿主吞噬消耗症候群，其特徵是系統性發炎、無意識的瘦體重損失、蛋白質負平衡、食慾不振和肌肉萎縮。它是由多種慢性疾病的發生引起的，包括結核病（TB）、多發性硬化症、慢性阻塞性肺病（COPD）和人類免疫缺陷病毒（HIV）。癌症惡病質可以使用多種療法來治療，例如黃體素、皮質類固醇和聯合療法。其中，黃體素是一種合成或天然類固醇激素，可改善食慾並促進體重增加，而皮質類固醇有助於減輕發炎和抑制過度活躍的免疫系統。

癌症惡病質市場趨勢：

癌症和惡病質的盛行率不斷增加，特別是在不斷增加的老年人口中，促進了對先進治療方法和藥物的需求，這反過來又主要推動了市場的成長。消費者對治療癌症惡病質的新型治療藥物的可用性的認知不斷提高，進一步支持了這一點。此外，患者轉向透過藥物、非藥物治療和臨床試驗改善去脂體重（LBM）的聯合治療的傾向正在成為另一個生長誘導因素。與此一致的是，用於改善消化的多種食慾興奮劑（例如醋酸甲地孕酮、地塞米松和甲基強的松龍）的廣泛使用也促進了市場的成長。此外，強調開發治療癌症惡病質的有效藥物的重大技術進步進一步推動了市場成長。除此之外，各國政府機構和非政府組織（NGO）採取了許多有利舉措，提高人們對癌症惡病質的原因、症狀和使用先進治療的好處的認知，這為癌症惡病質的發展創造了積極的前景。

本報告回答的關鍵問題

  • 2023 年全球癌症惡病質市場規模有多大？
  • 2024-2032年全球癌症惡病質市場的預期成長率是多少？
  • 推動全球癌症惡病質市場的關鍵因素是什麼？
  • COVID-19 對全球癌症惡病質市場有何影響？
  • 基於治療方法的全球癌症惡病質市場的詳細情形如何？
  • 根據作用方式，全球癌症惡病質市場的細分如何？
  • 全球癌症惡病質市場的關鍵地區有哪些？
  • 全球癌症惡病質市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球癌症惡病質市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依治療學分類

  • 黃體素
    • 市場走向
    • 市場預測
  • 皮質類固醇
    • 市場走向
    • 市場預測
  • 聯合療法
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：市場區隔：按行動模式

  • 食慾刺激器
    • 市場走向
    • 市場預測
  • 減肥穩定劑
    • 市場走向
    • 市場預測

第 8 章：市場區隔：按配銷通路

  • 醫院商店
    • 市場走向
    • 市場預測
  • 零售藥房
    • 市場走向
    • 市場預測
  • 網路藥房
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • AAVogen Inc.
    • Actimed Therapeutics Ltd.
    • Aphios Corporation
    • Artelo Biosciences Inc.
    • AVEO Pharmaceuticals Inc.
    • Fresenius Kabi AG (Fresenius SE & Co. KGaA)
    • Helsinn Healthcare SA
    • Merck & Co. Inc.
    • NGM Biopharmaceuticals Inc.
    • Pfizer Inc.
    • Tetra Bio-Pharma
Product Code: SR112024A5338

The global cancer cachexia market size reached US$ 2.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.0 Billion by 2032, exhibiting a growth rate (CAGR) of 4.1% during 2024-2032.

Cancer cachexia refers to a multifactorial, host-phagocytic, wasting syndrome that is characterized by systematic inflammation, involuntary loss of lean body mass, negative protein balance, loss of appetite and muscle atrophy. It is caused due to the occurrence of various chronic diseases, including tuberculosis (TB), multiple sclerosis, chronic obstructive pulmonary disease (COPD) and human immunodeficiency virus (HIV). Cancer cachexia can be treated with the utilization of various therapeutics, such as progestogen, corticosteroid, and combination therapy. Amongst these, a progestogen is a synthetic or natural steroid hormone that improves appetite and promotes weight gain, whereas corticosteroid assists in mitigating inflammation and suppressing overactive immune systems.

Cancer Cachexia Market Trends:

The increasing prevalence of cancer and cachexia, especially amongst the rising geriatric populations, is facilitating the demand for advanced therapeutic treatment and drugs, which in turn, is primarily driving the market growth. This is further supported by the increasing awareness amongst consumers regarding the availability of novel therapeutic drugs to treat cancer cachexia. Additionally, the shifting inclination of patients toward combinational therapies for improving lean body mass (LBM) through pharmacological, non-pharmacological therapies and clinical trials is acting as another growth-inducing factor. In line with this, the extensive utilization of several appetite stimulants, such as megestrol acetate, dexamethasone, and methylprednisolone, for improving digestion is also contributing to the market growth. Moreover, significant technological advancements that are emphasizing on the development of effective medicines for cancer cachexia treatment are further propelling the market growth. Apart from this, the numerous favorable initiatives being undertaken by the government bodies of various countries and non-governmental organizations (NGOs) for sensitizing people regarding the causes of cancer cachexia, their symptoms and benefits of using advanced treatments are creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global cancer cachexia market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on therapeutics, mode of action and distribution channel.

Breakup by Therapeutics:

Progestogens

Corticosteroids

Combination Therapy

Others

Breakup by Mode of Action:

Appetite Stimulators

Weight Loss Stabilizers

Breakup by Distribution Channel:

Hospital Stores

Retail Pharmacy

Online Pharmacy

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AAVogen Inc., Actimed Therapeutics Ltd., Aphios Corporation, Artelo Biosciences Inc., AVEO Pharmaceuticals Inc., Fresenius Kabi AG (Fresenius SE & Co. KGaA), Helsinn Healthcare SA, Merck & Co. Inc., NGM Biopharmaceuticals Inc., Pfizer Inc. and Tetra Bio-Pharma.

Key Questions Answered in This Report

  • 1. What was the size of the global cancer cachexia market in 2023?
  • 2. What is the expected growth rate of the global cancer cachexia market during 2024-2032?
  • 3. What are the key factors driving the global cancer cachexia market?
  • 4. What has been the impact of COVID-19 on the global cancer cachexia market?
  • 5. What is the breakup of the global cancer cachexia market based on the therapeutics?
  • 6. What is the breakup of the global cancer cachexia market based on the mode of action?
  • 7. What are the key regions in the global cancer cachexia market?
  • 8. Who are the key players/companies in the global cancer cachexia market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cancer Cachexia Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Therapeutics

  • 6.1 Progestogens
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Corticosteroids
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Combination Therapy
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Mode of Action

  • 7.1 Appetite Stimulators
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Weight Loss Stabilizers
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Stores
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacy
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AAVogen Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Actimed Therapeutics Ltd.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Aphios Corporation
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Artelo Biosciences Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 AVEO Pharmaceuticals Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Fresenius Kabi AG (Fresenius SE & Co. KGaA)
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 SWOT Analysis
    • 14.3.7 Helsinn Healthcare SA
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Merck & Co. Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 NGM Biopharmaceuticals Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Pfizer Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Tetra Bio-Pharma
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials

List of Figures

  • Figure 1: Global: Cancer Cachexia Market: Major Drivers and Challenges
  • Figure 2: Global: Cancer Cachexia Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Cancer Cachexia Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Cancer Cachexia Market: Breakup by Therapeutics (in %), 2023
  • Figure 5: Global: Cancer Cachexia Market: Breakup by Mode of Action (in %), 2023
  • Figure 6: Global: Cancer Cachexia Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Cancer Cachexia Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Cancer Cachexia (Progestogens) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Cancer Cachexia (Progestogens) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Cancer Cachexia (Corticosteroids) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Cancer Cachexia (Corticosteroids) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Cancer Cachexia (Combination Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Cancer Cachexia (Combination Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Cancer Cachexia (Other Therapeutics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Cancer Cachexia (Other Therapeutics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Cancer Cachexia (Appetite Stimulators) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Cancer Cachexia (Appetite Stimulators) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Cancer Cachexia (Weight Loss Stabilizers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Cancer Cachexia (Weight Loss Stabilizers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Cancer Cachexia (Hospital Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Cancer Cachexia (Hospital Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Cancer Cachexia (Retail Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Cancer Cachexia (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Cancer Cachexia (Online Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Cancer Cachexia (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: North America: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: North America: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: United States: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: United States: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Canada: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Canada: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Asia-Pacific: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Asia-Pacific: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: China: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: China: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Japan: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Japan: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: India: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: India: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: South Korea: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: South Korea: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Australia: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Australia: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Indonesia: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Indonesia: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Others: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Others: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Europe: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Europe: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Germany: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Germany: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: France: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: France: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: United Kingdom: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: United Kingdom: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Italy: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Italy: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Spain: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Spain: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Russia: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Russia: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Others: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Others: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Latin America: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Latin America: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Brazil: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Brazil: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Mexico: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Mexico: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Others: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Others: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Middle East and Africa: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Middle East and Africa: Cancer Cachexia Market: Breakup by Country (in %), 2023
  • Figure 74: Middle East and Africa: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Global: Cancer Cachexia Industry: SWOT Analysis
  • Figure 76: Global: Cancer Cachexia Industry: Value Chain Analysis
  • Figure 77: Global: Cancer Cachexia Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cancer Cachexia Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Cancer Cachexia Market Forecast: Breakup by Therapeutics (in Million US$), 2024-2032
  • Table 3: Global: Cancer Cachexia Market Forecast: Breakup by Mode of Action (in Million US$), 2024-2032
  • Table 4: Global: Cancer Cachexia Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Cancer Cachexia Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Cancer Cachexia Market: Competitive Structure
  • Table 7: Global: Cancer Cachexia Market: Key Players